Safety issues related to the administration of ribavirin.
Krilov
Leonard R
LR
Department of Pediatrics, Winthrop University Hospital, Mineola, NY, USA.
D000014:Abnormalities, Drug-Induced; D000042:Absorption; D000280:Administration, Inhalation; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006282:Health Personnel; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D019570:Inhalation Exposure; D016273:Occupational Exposure; D011247:Pregnancy; D012134:Respiratory Protective Devices; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy*; D012254:Ribavirin / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D018570:Risk Assessment; D013723:Teratogens
D000998:Antiviral Agents; D013723:Teratogens; D012254:Ribavirin